Physician profile
Daniel Rabinowitz
NPI 1275928541
$5,422.93
in general payments reported to CMS, 2019-2025
17 companies · $3,649 in 2025
The $3,649 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $733 · 2023: $790 · 2024: $251 · 2025: $3,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,222 · Consulting Fee: $1,500 · Travel and Lodging: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,222.48 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $967.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $1,813.94 | 2022-2025 | |
| Histosonics, INC. | $1,192.41 | 2025 | |
| Angiodynamics, INC. | $497.93 | 2023-2025 | Nanoknife |
| Boston Scientific Corporation | $491.32 | 2022-2025 | Ams 700, Rezum Generator, General - Erectile Dysfunction |
| Teleflex LLC | $341.66 | 2023-2025 | Urolift, Barrigel |
| Coloplast Corp | $222.79 | 2022-2023 | Altis |
| Olympus America INC. | $204.97 | 2022-2025 | Itind System |
| Calyxo, INC. | $148.61 | 2024-2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $120.29 | 2023 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $92.84 | 2023 | Lynparza |
| Axogen | $91.61 | 2025 | |
| Axonics, INC. | $74.00 | 2023-2024 | Axonics |
| Medtronic, INC. | $49.92 | 2023 | Minimed 780g, Interstim |
| Dendreon Pharmaceuticals LLC | $32.00 | 2022 | |
| Laborie Medical Technologies Corp. | $18.08 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $15.81 | 2022 | |
| Abbvie INC. | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rabinowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.